Global Recurrent Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jan-2021
No. of pages: 128
Inquire Before Buying

Recurrent Glioblastoma Multiforme Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recurrent Glioblastoma Multiforme Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- AU-105

- Axitinib

- AXL-1717

- AZD-7451

- Others

Segment by Application

- Hospital

- Clinic

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Boehringer Ingelheim GmbH

- Boston Biomedical, Inc.

- Bristol-Myers Squibb Company

- Cantex Pharmaceuticals, Inc.

- Cavion LLC

- Celldex Therapeutics, Inc.

- Coherus BioSciences, Inc.

- Cortice Biosciences, Inc.

- Eisai

- Cantex Pharmaceuticals, Inc.

- Cavion LLC

- ERC Belgium SA

- GenSpera, Inc.

- Genzyme Corporation

- GW Pharmaceuticals Plc

Global Recurrent Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recurrent Glioblastoma Multiforme Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AU-105
1.2.3 Axitinib
1.2.4 AXL-1717
1.2.5 AZD-7451
1.2.6 Others
1.3 Market by Application
1.3.1 Global Recurrent Glioblastoma Multiforme Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recurrent Glioblastoma Multiforme Treatment Market Perspective (2016-2027)
2.2 Recurrent Glioblastoma Multiforme Treatment Growth Trends by Regions
2.2.1 Recurrent Glioblastoma Multiforme Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recurrent Glioblastoma Multiforme Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Recurrent Glioblastoma Multiforme Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Recurrent Glioblastoma Multiforme Treatment Industry Dynamic
2.3.1 Recurrent Glioblastoma Multiforme Treatment Market Trends
2.3.2 Recurrent Glioblastoma Multiforme Treatment Market Drivers
2.3.3 Recurrent Glioblastoma Multiforme Treatment Market Challenges
2.3.4 Recurrent Glioblastoma Multiforme Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recurrent Glioblastoma Multiforme Treatment Players by Revenue
3.1.1 Global Top Recurrent Glioblastoma Multiforme Treatment Players by Revenue (2016-2021)
3.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Recurrent Glioblastoma Multiforme Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recurrent Glioblastoma Multiforme Treatment Revenue
3.4 Global Recurrent Glioblastoma Multiforme Treatment Market Concentration Ratio
3.4.1 Global Recurrent Glioblastoma Multiforme Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recurrent Glioblastoma Multiforme Treatment Revenue in 2020
3.5 Recurrent Glioblastoma Multiforme Treatment Key Players Head office and Area Served
3.6 Key Players Recurrent Glioblastoma Multiforme Treatment Product Solution and Service
3.7 Date of Enter into Recurrent Glioblastoma Multiforme Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recurrent Glioblastoma Multiforme Treatment Breakdown Data by Type
4.1 Global Recurrent Glioblastoma Multiforme Treatment Historic Market Size by Type (2016-2021)
4.2 Global Recurrent Glioblastoma Multiforme Treatment Forecasted Market Size by Type (2022-2027)
5 Recurrent Glioblastoma Multiforme Treatment Breakdown Data by Application
5.1 Global Recurrent Glioblastoma Multiforme Treatment Historic Market Size by Application (2016-2021)
5.2 Global Recurrent Glioblastoma Multiforme Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Recurrent Glioblastoma Multiforme Treatment Market Size (2016-2027)
6.2 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Type
6.2.1 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021)
6.2.2 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027)
6.2.3 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2027)
6.3 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Application
6.3.1 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021)
6.3.2 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027)
6.3.3 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2027)
6.4 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Country
6.4.1 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2016-2021)
6.4.2 North America Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Recurrent Glioblastoma Multiforme Treatment Market Size (2016-2027)
7.2 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Type
7.2.1 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021)
7.2.2 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027)
7.2.3 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2027)
7.3 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Application
7.3.1 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021)
7.3.2 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027)
7.3.3 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2027)
7.4 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Country
7.4.1 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2016-2021)
7.4.2 Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size (2016-2027)
8.2 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Type
8.2.1 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Application
8.3.1 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Region
8.4.1 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size (2016-2027)
9.2 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Type
9.2.1 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2027)
9.3 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Application
9.3.1 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2027)
9.4 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Country
9.4.1 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size (2016-2027)
10.2 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Type
10.2.1 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Application
10.3.1 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Country
10.4.1 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Details
11.1.2 Boehringer Ingelheim GmbH Business Overview
11.1.3 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Introduction
11.1.4 Boehringer Ingelheim GmbH Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.1.5 Boehringer Ingelheim GmbH Recent Development
11.2 Boston Biomedical, Inc.
11.2.1 Boston Biomedical, Inc. Company Details
11.2.2 Boston Biomedical, Inc. Business Overview
11.2.3 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Introduction
11.2.4 Boston Biomedical, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.2.5 Boston Biomedical, Inc. Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Cantex Pharmaceuticals, Inc.
11.4.1 Cantex Pharmaceuticals, Inc. Company Details
11.4.2 Cantex Pharmaceuticals, Inc. Business Overview
11.4.3 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Introduction
11.4.4 Cantex Pharmaceuticals, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.4.5 Cantex Pharmaceuticals, Inc. Recent Development
11.5 Cavion LLC
11.5.1 Cavion LLC Company Details
11.5.2 Cavion LLC Business Overview
11.5.3 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Introduction
11.5.4 Cavion LLC Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.5.5 Cavion LLC Recent Development
11.6 Celldex Therapeutics, Inc.
11.6.1 Celldex Therapeutics, Inc. Company Details
11.6.2 Celldex Therapeutics, Inc. Business Overview
11.6.3 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Introduction
11.6.4 Celldex Therapeutics, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.6.5 Celldex Therapeutics, Inc. Recent Development
11.7 Coherus BioSciences, Inc.
11.7.1 Coherus BioSciences, Inc. Company Details
11.7.2 Coherus BioSciences, Inc. Business Overview
11.7.3 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Introduction
11.7.4 Coherus BioSciences, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.7.5 Coherus BioSciences, Inc. Recent Development
11.8 Cortice Biosciences, Inc.
11.8.1 Cortice Biosciences, Inc. Company Details
11.8.2 Cortice Biosciences, Inc. Business Overview
11.8.3 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Introduction
11.8.4 Cortice Biosciences, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.8.5 Cortice Biosciences, Inc. Recent Development
11.9 Eisai
11.9.1 Eisai Company Details
11.9.2 Eisai Business Overview
11.9.3 Eisai Recurrent Glioblastoma Multiforme Treatment Introduction
11.9.4 Eisai Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.9.5 Eisai Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Details
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Introduction
11.10.4 Eli Lilly and Company Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.10.5 Eli Lilly and Company Recent Development
11.11 EnGeneIC Ltd
11.11.1 EnGeneIC Ltd Company Details
11.11.2 EnGeneIC Ltd Business Overview
11.11.3 EnGeneIC Ltd Recurrent Glioblastoma Multiforme Treatment Introduction
11.11.4 EnGeneIC Ltd Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.11.5 EnGeneIC Ltd Recent Development
11.12 ERC Belgium SA
11.12.1 ERC Belgium SA Company Details
11.12.2 ERC Belgium SA Business Overview
11.12.3 ERC Belgium SA Recurrent Glioblastoma Multiforme Treatment Introduction
11.12.4 ERC Belgium SA Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.12.5 ERC Belgium SA Recent Development
11.13 GenSpera, Inc.
11.13.1 GenSpera, Inc. Company Details
11.13.2 GenSpera, Inc. Business Overview
11.13.3 GenSpera, Inc. Recurrent Glioblastoma Multiforme Treatment Introduction
11.13.4 GenSpera, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.13.5 GenSpera, Inc. Recent Development
11.14 Genzyme Corporation
11.14.1 Genzyme Corporation Company Details
11.14.2 Genzyme Corporation Business Overview
11.14.3 Genzyme Corporation Recurrent Glioblastoma Multiforme Treatment Introduction
11.14.4 Genzyme Corporation Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.14.5 Genzyme Corporation Recent Development
11.15 GW Pharmaceuticals Plc
11.15.1 GW Pharmaceuticals Plc Company Details
11.15.2 GW Pharmaceuticals Plc Business Overview
11.15.3 GW Pharmaceuticals Plc Recurrent Glioblastoma Multiforme Treatment Introduction
11.15.4 GW Pharmaceuticals Plc Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.15.5 GW Pharmaceuticals Plc Recent Development
11.16 ImmunoCellular Therapeutics, Ltd.
11.16.1 ImmunoCellular Therapeutics, Ltd. Company Details
11.16.2 ImmunoCellular Therapeutics, Ltd. Business Overview
11.16.3 ImmunoCellular Therapeutics, Ltd. Recurrent Glioblastoma Multiforme Treatment Introduction
11.16.4 ImmunoCellular Therapeutics, Ltd. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021)
11.16.5 ImmunoCellular Therapeutics, Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Recurrent Glioblastoma Multiforme Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AU-105
Table 3. Key Players of Axitinib
Table 4. Key Players of AXL-1717
Table 5. Key Players of AZD-7451
Table 6. Key Players of Others
Table 7. Global Recurrent Glioblastoma Multiforme Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Recurrent Glioblastoma Multiforme Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Recurrent Glioblastoma Multiforme Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Recurrent Glioblastoma Multiforme Treatment Market Share by Regions (2016-2021)
Table 11. Global Recurrent Glioblastoma Multiforme Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Recurrent Glioblastoma Multiforme Treatment Market Share by Regions (2022-2027)
Table 13. Recurrent Glioblastoma Multiforme Treatment Market Trends
Table 14. Recurrent Glioblastoma Multiforme Treatment Market Drivers
Table 15. Recurrent Glioblastoma Multiforme Treatment Market Challenges
Table 16. Recurrent Glioblastoma Multiforme Treatment Market Restraints
Table 17. Global Recurrent Glioblastoma Multiforme Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Recurrent Glioblastoma Multiforme Treatment Market Share by Players (2016-2021)
Table 19. Global Top Recurrent Glioblastoma Multiforme Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recurrent Glioblastoma Multiforme Treatment as of 2020)
Table 20. Ranking of Global Top Recurrent Glioblastoma Multiforme Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Recurrent Glioblastoma Multiforme Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Recurrent Glioblastoma Multiforme Treatment Product Solution and Service
Table 24. Date of Enter into Recurrent Glioblastoma Multiforme Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Recurrent Glioblastoma Multiforme Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Recurrent Glioblastoma Multiforme Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Recurrent Glioblastoma Multiforme Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Boehringer Ingelheim GmbH Company Details
Table 65. Boehringer Ingelheim GmbH Business Overview
Table 66. Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Product
Table 67. Boehringer Ingelheim GmbH Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 68. Boehringer Ingelheim GmbH Recent Development
Table 69. Boston Biomedical, Inc. Company Details
Table 70. Boston Biomedical, Inc. Business Overview
Table 71. Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Product
Table 72. Boston Biomedical, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 73. Boston Biomedical, Inc. Recent Development
Table 74. Bristol-Myers Squibb Company Company Details
Table 75. Bristol-Myers Squibb Company Business Overview
Table 76. Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Product
Table 77. Bristol-Myers Squibb Company Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 78. Bristol-Myers Squibb Company Recent Development
Table 79. Cantex Pharmaceuticals, Inc. Company Details
Table 80. Cantex Pharmaceuticals, Inc. Business Overview
Table 81. Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Product
Table 82. Cantex Pharmaceuticals, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 83. Cantex Pharmaceuticals, Inc. Recent Development
Table 84. Cavion LLC Company Details
Table 85. Cavion LLC Business Overview
Table 86. Cavion LLC Recurrent Glioblastoma Multiforme Treatment Product
Table 87. Cavion LLC Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 88. Cavion LLC Recent Development
Table 89. Celldex Therapeutics, Inc. Company Details
Table 90. Celldex Therapeutics, Inc. Business Overview
Table 91. Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Product
Table 92. Celldex Therapeutics, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 93. Celldex Therapeutics, Inc. Recent Development
Table 94. Coherus BioSciences, Inc. Company Details
Table 95. Coherus BioSciences, Inc. Business Overview
Table 96. Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Product
Table 97. Coherus BioSciences, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 98. Coherus BioSciences, Inc. Recent Development
Table 99. Cortice Biosciences, Inc. Company Details
Table 100. Cortice Biosciences, Inc. Business Overview
Table 101. Cortice Biosciences, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 102. Cortice Biosciences, Inc. Recent Development
Table 103. Eisai Company Details
Table 104. Eisai Business Overview
Table 105. Eisai Recurrent Glioblastoma Multiforme Treatment Product
Table 106. Eisai Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 107. Eisai Recent Development
Table 108. Eli Lilly and Company Company Details
Table 109. Eli Lilly and Company Business Overview
Table 110. Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Product
Table 111. Eli Lilly and Company Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 112. Eli Lilly and Company Recent Development
Table 113. EnGeneIC Ltd Company Details
Table 114. EnGeneIC Ltd Business Overview
Table 115. EnGeneIC Ltd Recurrent Glioblastoma Multiforme Treatment Product
Table 116. EnGeneIC Ltd Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 117. EnGeneIC Ltd Recent Development
Table 118. ERC Belgium SA Company Details
Table 119. ERC Belgium SA Business Overview
Table 120. ERC Belgium SA Recurrent Glioblastoma Multiforme Treatment Product
Table 121. ERC Belgium SA Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 122. ERC Belgium SA Recent Development
Table 123. GenSpera, Inc. Company Details
Table 124. GenSpera, Inc. Business Overview
Table 125. GenSpera, Inc. Recurrent Glioblastoma Multiforme Treatment Product
Table 126. GenSpera, Inc. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 127. GenSpera, Inc. Recent Development
Table 128. Genzyme Corporation Company Details
Table 129. Genzyme Corporation Business Overview
Table 130. Genzyme Corporation Recurrent Glioblastoma Multiforme Treatment Product
Table 131. Genzyme Corporation Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 132. Genzyme Corporation Recent Development
Table 133. GW Pharmaceuticals Plc Company Details
Table 134. GW Pharmaceuticals Plc Business Overview
Table 135. GW Pharmaceuticals Plc Recurrent Glioblastoma Multiforme Treatment Product
Table 136. GW Pharmaceuticals Plc Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 137. GW Pharmaceuticals Plc Recent Development
Table 138. ImmunoCellular Therapeutics, Ltd. Company Details
Table 139. ImmunoCellular Therapeutics, Ltd. Business Overview
Table 140. ImmunoCellular Therapeutics, Ltd. Recurrent Glioblastoma Multiforme Treatment Product
Table 141. ImmunoCellular Therapeutics, Ltd. Revenue in Recurrent Glioblastoma Multiforme Treatment Business (2016-2021) & (US$ Million)
Table 142. ImmunoCellular Therapeutics, Ltd. Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recurrent Glioblastoma Multiforme Treatment Market Share by Type: 2020 VS 2027
Figure 2. AU-105 Features
Figure 3. Axitinib Features
Figure 4. AXL-1717 Features
Figure 5. AZD-7451 Features
Figure 6. Others Features
Figure 7. Global Recurrent Glioblastoma Multiforme Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Recurrent Glioblastoma Multiforme Treatment Report Years Considered
Figure 12. Global Recurrent Glioblastoma Multiforme Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Recurrent Glioblastoma Multiforme Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Recurrent Glioblastoma Multiforme Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Recurrent Glioblastoma Multiforme Treatment Market Share by Regions (2022-2027)
Figure 16. Global Recurrent Glioblastoma Multiforme Treatment Market Share by Players in 2020
Figure 17. Global Top Recurrent Glioblastoma Multiforme Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recurrent Glioblastoma Multiforme Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Recurrent Glioblastoma Multiforme Treatment Revenue in 2020
Figure 19. Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Recurrent Glioblastoma Multiforme Treatment Market Share by Type (2016-2027)
Figure 23. North America Recurrent Glioblastoma Multiforme Treatment Market Share by Application (2016-2027)
Figure 24. North America Recurrent Glioblastoma Multiforme Treatment Market Share by Country (2016-2027)
Figure 25. United States Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Recurrent Glioblastoma Multiforme Treatment Market Share by Type (2016-2027)
Figure 29. Europe Recurrent Glioblastoma Multiforme Treatment Market Share by Application (2016-2027)
Figure 30. Europe Recurrent Glioblastoma Multiforme Treatment Market Share by Country (2016-2027)
Figure 31. Germany Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Share by Region (2016-2027)
Figure 41. China Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Recurrent Glioblastoma Multiforme Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Ind
  • Global Anesthesia Color Ultrasound Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - With Puncture Probe - Without Puncture Probe Segment by Application - Anesthesia - PI......
  • Global Anaesthesia Ceiling Pendant Systems Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Fixed - Fixed Retractable - Single Arm Movable - Multi Arm Movable Segment by Applica......
  • Global Patient Warming Devices Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Electromagnetic Heating - Infrared Heating - Resistance Heating - Other Segment by Ap......
  • Global Arterial Vascular Stents Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Self Expansion - Balloon Dilatation Segment by Application - Hospitals & Cardiac Centers......
  • Global Cerebral Vascular Stents Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tantalum - Medical Stainless Steel - Nitinol - Other Segment by Application - ......
  • Global Neurovascular Stents Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Carotid Artery Stents - Intracranial Stents Segment by Application - Hospital & Clinic......
  • Global Endovascular Stent Grafts Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Synthetic - Biological - Biosynthetic Segment by Application - Hospital - Clin......
  • Global Medical Ceramics Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Bioinert Ceramics - Bioactive Ceramics - Bioresorbable Ceramics Segment by Application......
  • Global Retractable Needle Safety Syringes Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Automatic - Manual Segment by Application - Hospitals - Clinics - Ambulatory S......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs